News

Article

Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy?

Sponsored Supplement: Could targeting retinal non-perfusion be the key to achieving true disease modification in diabetic retinopathy?

The triad of inflammation, neuropathy, and vasculopathy plays a key role in the development and progression of diabetic retinopathy (DR).1 Dr. Varun Chaudhary and Dr. Patrick Bussfeld, discuss how retinal non-perfusion (RNP) specifically drives disease progression and why it should be explored as a treatment target.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
© 2025 MJH Life Sciences

All rights reserved.